https://www.diabesityrounds.com/a/real-world-cohort-sglt-2-inhibitors-linked-to-lower-kidney-failure-risk-than-glpDiabesity Roundsen2026-11-03T20:17:15.621ZReal-world cohort: SGLT-2 inhibitors linked to lower kidney failure risk than GLP-1 RAshttps://www.diabesityrounds.com/a/hypoglycaemia-linked-to-qtc-prolongation-in-type-1-and-type-2-diabetes-meta-analDiabesity Roundsen2026-11-03T20:02:09.742ZHypoglycaemia linked to QTc prolongation in type 1 and type 2 diabetes: meta-analysishttps://www.diabesityrounds.com/a/semaglutide-2-4-mg-in-obesity-related-hfpef-with-type-2-diabetes-phase-3-registrDiabesity Roundsen2026-11-02T20:02:53.042ZSemaglutide 2.4 mg in obesity-related HFpEF with type 2 diabetes: phase 3 registry results